5 Key Takeaways

• 1

  Scientists in China have developed a method to mass-produce cancer-fighting NK cells from a single stem cell.

• 2

  The new approach uses early-stage cord blood stem cells, achieving higher yields and improved consistency in cell therapy.

• 3

  The three-step process includes expansion, differentiation, and large-scale maturation of CD34+ hematopoietic stem cells.

• 4

  One stem cell can generate approximately 14 million NK cells, significantly reducing viral vector requirements and costs.

• 5

  In leukemia mouse models, CAR-engineered NK cells suppressed tumor growth and retained potency after cryopreservation.